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Abstract The methionine analogue 2-amino-5-hexenoic acid
(homoallylglycine, Hag) can be utilized by Escherichia coli in the
initiation and elongation steps of protein biosynthesis. Use of an
E. coli methionine auxotroph and Hag-supplemented medium
resulted in replacement of ca. 85% of the methionine residues in
mouse dihydrofolate reductase expressed under control of a
bacteriophage T5 promoter. N-terminal sequencing indicated
92 þ 5% occupancy of the initiator site by Hag. The vinyl
function of Hag remains intact in the purified protein and
suggests new chemistries for modification of natural and
artificial proteins prepared in bacterial hosts.
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1. Introduction
Protein engineering constitutes a powerful tool for modi¢-
cation of the structural, catalytic and binding activities of
natural proteins and for the de novo design of novel macro-
molecular materials [1^4]. At the same time, the speci¢city of
protein biosynthesis limits the scope of in vivo engineering
methods, in that the pool of potential monomers is restricted
to the natural proteinogenic amino acids and those analogues
that can be activated and charged to transfer RNAs. The
number of analogues shown conclusively to exhibit transla-
tional activity in vivo is small, and the range of chemical
functionality accessible via this route remains modest. The
introduction of new building blocks for protein synthesis,
and in particular, of new functional groups with novel pat-
terns of reactivity, will expand signi¢cantly the scope and
impact of protein engineering methods.
Several analogues of methionine (1) (speci¢cally selenome-
thionine [5], telluromethionine [6], norleucine [7], tri£uorome-
thionine [8] and ethionine [9]) have been shown to exhibit
translational activity in bacterial hosts. These results turned
our attention to homoallylglycine (Hag, 2), which we antici-
pated might serve as a vehicle for the introduction of reactive
terminal alkene functionality into proteins made in vivo. Hag
has been exploited to e¡ect ‘covalent capture’ of hydrogen-
bonded peptide dimers via ruthenium-catalyzed ole¢n meta-
thesis [10], and the versatile chemistry of alkenes [11] suggests
other novel approaches to the derivatization of Hag residues
in engineered proteins. Although Hag has recently been iso-
lated by ethanol extraction of the fruit body of the fungus
Amanita gymnopus [12], we are unaware of previous studies
of the in vivo translational activity of any of the aminohex-
enoic acids. We show herein that Hag functions e⁄ciently as a
methionine surrogate in the initiation and elongation steps of
protein synthesis in Escherichia coli
.
2. Materials and methods
2.1. Synthesis of Hag
DL-Hag was prepared by alkylation of diethyl acetamidomalonate
with 3-butenyl tosylate followed by hydrolysis to the amino acid
[13,14]. NMR data obtained for Hag were in agreement with [12].
Similar methods were used for synthesis of the cis- and trans-2-ami-
no-4-hexenoic acids.
2.2. Determination of translational activity
A bacterial host (designated CAG18491/pREP4/pQE15) suitable for
testing the translational activity of Hag and its internal isomers cis-
and trans-2-amino-4-hexenoic acids (3 and 4, respectively) was pre-
pared by transformation of E. coli strain CAG18491, a methionine
auxotroph, with the repressor plasmid pREP4 and the expression
plasmid pQE-15 (QIAGEN, Inc., Santa Clarita, CA, USA). pQE-15
encodes mouse dihydrofolate reductase (mDHFR) under control of a
bacteriophage T5 promoter, as well as an N-terminal hexahistidine
sequence that facilitates puri¢cation of the protein by immobilized
metal a⁄nity chromatography. mDHFR contains seven methionine
residues, each a potential site for substitution of methionine by the
aminohexenoic acids
.
The translational activity of the aminohexenoic acids was investi-
gated on a 5-ml scale. A CAG18491/pREP4/pQE15 culture was grown
in M9AA medium supplemented with glucose, thiamine, MgSO4 and
the antibiotics kanamycin and ampicillin, until the optical density of
the culture (OD600) reached a value of 0.9. Cells were sedimented by
centrifugation and resuspended in the same medium, without methio-
nine. Negative (no methionine or analogue added after the medium
shift) and positive (addition of 40 mg/l (0.27 mM) methionine) con-
trols were performed. In order to test translational activity, the ana-
logue of interest was added to the medium at a concentration of 40
mg/l (0.31 mM), and protein expression was induced by addition of
0.4 mM isopropyl L-D-thiogalactopyranoside (IPTG). Cell growth and
protein expression were followed over a 4-h period.
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2.3. Isolation of alkene-substituted mDHFR
The procedure described above was repeated on a 1-l scale. After 3 h
the cells were harvested, and the target protein (mDHFR-E) was
puri¢ed by immobilized metal a⁄nity chromatography. mDHFR-E
eluted in the pH 4.5 (8 M urea) wash, and was isolated by dialysis
against distilled H2O followed by lyophilization.
3. Results and discussion
CAG18491/pREP4/pQE15 cultures were grown in M9AA
medium, sedimented by centrifugation, and resuspended in
the test medium, which contained either: (i) no methionine
or analogue (negative control) ; (ii) methionine (positive con-
trol); or (iii) the analogue of interest. Expression of mDHFR
was induced by addition of IPTG, and cell growth and pro-
tein synthesis were followed over a 4-h period. No induction
was observed in the negative control culture or in cultures
supplemented with either of the 2-amino-4-hexenoic acids.
On the other hand, supplementation of CAG18491/pREP4/
pQE15 cultures with methionine or with Hag led to appear-
ance of new protein bands at the position expected for
mDHFR in SDS-polyacrylamide gel electrophoresis (Fig. 1).
Thus, of the three aminohexenoic acids tested, only Hag, the
terminally-unsaturated isomer, shows signi¢cant activity as a
methionine surrogate in bacterial protein synthesis. The yield
of target protein (mDHFR-E) isolated from Hag-supple-
mented cultures was 8 mg/l.
Amino acid analysis of puri¢ed mDHFR-E indicated that
the protein contained 0.5 mol% methionine vs. the expected
value of 3.7 mol%. Hag is unstable under the conditions used
for amino acid analysis, and could not be observed directly by
this method; however, assumption that the diminution in me-
thionine content is due to replacement by Hag leads to an
estimate of 86 þ 5% substitution by the analogue. N-terminal
sequencing of mDHFR-E (which does not degrade the ana-
logue) showed directly that 92 þ 5% of the initiator methionine
was replaced by Hag. Retention of the N-terminal residue in
both mDHFR and mDHFR-E is consistent with the known
correlation between the extent of methionine excision from E.
coli proteins and the identity of the penultimate amino acid
[15].
Further evidence for incorporation of the alkene function
was obtained via 1H-NMR spectroscopy (Fig. 2). Comparison
of the alkene proton regions of the spectra of mDHFR-E
(Fig. 2b and d), mDHFR (Fig. 2a) and Hag (Fig. 2c) clearly
shows the vinyl CH resonance of Hag at a chemical shift of
5.7 ppm in the spectrum of mDHFR-E. The vinyl CH2 signal
is suppressed because it coincides with the HOD resonance.
Integration indicates replacement of 77 þ 5% of the methio-
nine residues of mDHFR.
These results demonstrate conclusively that Hag serves as a
methionine surrogate in the initiation and elongation steps of
protein synthesis in E. coli. In contrast, the internal alkene
isomers, the cis- and trans-2-amino-4-hexenoic acids, do not
support protein synthesis in the assay reported here; appar-
ently the conformational restriction imposed on the four-car-
bon side chain by the planar internal double bond either (i)
suppresses recognition by the bacterial methionyl-tRNA syn-
thetase; (ii) inhibits activation or charging by the enzyme; or
(iii) partitions the analogue into the editing pathway of the
synthetase subsequent to activation [16,17]. Although the
crystal structure of an active tryptic fragment of the synthe-
tase (complexed with ATP) has been reported [18], the corre-
sponding structures of the complexes with methionine or with
tRNAMet are not yet available. Inferences concerning the
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Fig. 1. Identi¢cation of mDHFR and mDHFR-E by SDS-polyacryl-
amide gel electrophoresis. t = 0: time of induction by addition of 0.4
mM IPTG; t = 1: 80 min after induction; t = 2: 2.5 h after induc-
tion; t = 3: 4 h after induction. Lane 1: no induction; lanes 2^3:
M9AA medium without L-methionine or Hag; lanes 4^5: M9AA
medium supplemented with 0.27 mM L-methionine; lanes 6^8: me-
dium supplemented with 0.31 mM DL-Hag.
Fig. 2. 1H-NMR spectra (D2O, 500.13 MHz) of (a) mDHFR, (b) mDHFR-E, (c) Hag and (d) mDHFR-E alkene proton region.
J.C.M. van Hest, D.A. Tirrell/FEBS Letters 428 (1998) 68^70 69
mechanism of amino acid recognition must therefore be made
with care, and have heretofore been made indirectly, on the
basis of sequence comparison and site-directed mutagenesis
[17,19,20].
The observation that Hag can be incorporated into E. coli
proteins in vivo creates important new opportunities for pro-
tein engineering. For example, recent advances in the chem-
istry of ole¢n metathesis have led to the development of tran-
sition metal carbenes that catalyze e⁄cient cyclization of
peptides containing Hag [10] or allylglycine [21], and that
retain catalytic activity in aqueous media [22]. Analogous re-
actions on genetically engineered arti¢cial proteins could be
used for crosslinking or side-chain modi¢cation, and because
Hag occupies the initiator site, for the introduction of new
endgroups, tethering of chains on surfaces, or the synthesis of
block copolymers. With respect to natural proteins, it remains
to be shown that alkene derivatization can be accomplished
without interference from reactions occurring at residues oth-
er than Hag; nevertheless, the possibilities are intriguing even
for the alkene-functional proteins per se, since methionine
residues have been proposed to play important roles in con-
trolling intersubunit interactions and protein-protein recogni-
tion processes [8,23,24].
Finally, we note that the method reported herein for intro-
duction of novel functionality into proteins is complementary
to the in vitro methods, involving chemical misacylation of
suppressor tRNAs, under development elsewhere [25]. The in
vitro approach accommodates a broader range of side-chain
structures, and the use of suppressor tRNAs allows the non-
natural amino acid to be inserted at a single programmed site
in the protein of interest. The in vivo method described here,
on the other hand, provides substantially larger yields of the
target protein, avoids the di⁄culties of chemical misacylation
and competitive translational termination at the site of sub-
stitution, and is better suited to the synthesis of proteins
modi¢ed at multiple sites, which are ¢nding increasing use
in crystallographic determination of protein structure [5].
Both methods illustrate the subtle and surprising synthetic
versatility of the protein biosynthetic apparatus of bacterial
cells.
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